Synergistic Effect of Aβ42 and Tau Protein in Alzheimer's Disease

Alzheimer's disease (AD) is a neurodegenerative disease that can't be cured at present, which is different from what we call infectious diseases, and is usually related to senile dementia. Although there is no radical cure at present, early diagnosis and intervention can delay the progress of the disease and improve the quality of life of patients. The mechanism of Aβ42 and Tau protein in AD is of great significance for early diagnosis and treatment of diseases. In this paper, the interaction between these two proteins is deeply analyzed, and their role in the pathological development of AD is discussed, and how to use this knowledge to improve the accuracy of clinical diagnosis and develop new treatment strategies.